Diabetes Care 41(12):25602569
However, most findings arise from in vitro studies, warranting further research through in vivo models and clinical trials to validate their neuroprotective effects and mechanisms
Submit a written appeal, a Letter of Medical Necessity from the prescriber, chart notes, BMI history, and documentation of the 6-month weight management program
Despite its unlicensed status, retatrutide has begun appearing on the grey market, often sold as a 'research peptide' or 'research chemical'
Injection site reactions are the most frequent skin-related finding and typically present as localized redness, mild swelling, or tenderness at the injection site